tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market
HBIO
Harvard Bioscience
RESEARCH TOOLSreports

Harvard Bioscience (HBIO) Income Statement

276 Followers

Harvard Bioscience Income Statement

Last quarter (Q4 2025), Harvard Bioscience's total revenue was $23.73M, a decrease of -3.34% from the same quarter last year. In Q4, Harvard Bioscience's net income was $-2.85M. See Harvard Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 86.55M$ 94.14M$ 112.25M$ 113.33M$ 118.90M
Gross Profit
$ 45.88M$ 54.77M$ 66.07M$ 60.82M$ 67.65M
Operating Expenses
$ 46.51M$ 60.98M$ 64.18M$ 67.75M$ 65.59M
Depreciation and Amortization
$ 5.95M$ 6.98M$ 7.00M$ 7.58M$ 7.62M
EBITDA
$ 5.32M$ -1.47M$ 8.03M$ 944.00K$ 9.02M
Operating Income
$ -629.00K$ -6.21M$ 1.89M$ -6.93M$ 2.07M
Other Income/Expenses
$ -56.76M$ -5.45M$ -4.45M$ -2.25M$ -2.21M
Pretax Income
$ -57.39M$ -11.66M$ -2.56M$ -9.18M$ -140.00K
Net Income
$ -56.70M$ -12.40M$ -3.42M$ -9.52M$ -288.00K
Per Share Metrics
Basic EPS
$ -12.80$ -2.80$ -0.81$ -2.30$ -0.07
Diluted EPS
$ -12.80$ -2.80$ -0.81$ -2.30$ -0.07
Weighted Average Shares Outstanding
 4.44M 4.35M 4.24M 4.14M 4.03M
Weighted Average Shares Outstanding (Diluted)
 4.44M 4.35M 4.24M 4.14M 4.03M
Currency in USD

Harvard Bioscience Earnings and Revenue History